Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.31 BRL | -0.26% | -2.46% | -37.17% |
May. 07 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 20 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 |
Business Summary
Number of employees: 1,900
Sales per Business
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Institutional
86.0
%
| 1,277 | 90.8 % | 1,181 | 86.0 % | -7.58% |
Non-Institutional
14.0
%
| 129 | 9.2 % | 192 | 14.0 % | +48.29% |
Sales per region
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brazil
91.4
%
| 1,282 | 91.1 % | 1,254 | 91.4 % | -2.15% |
Colombia
3.2
%
| 34 | 2.4 % | 44 | 3.2 % | +27.65% |
Uruguay
2.9
%
| 55 | 3.9 % | 40 | 2.9 % | -28.14% |
United States
2.0
%
| 15 | 1.1 % | 27 | 2.0 % | +74.48% |
Chile
0.3
%
| 9 | 0.6 % | 5 | 0.3 % | -47.06% |
Peru
0.2
%
| 3 | 0.2 % | 3 | 0.2 % | +19.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 87-12-17 | |
Director of Finance/CFO | - | 18-04-30 | |
Roberto Altieri
CMP | Compliance Officer | - | 13-12-31 |
Chief Operating Officer | 58 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | - | |
Chief Operating Officer | 58 | - | |
Founder | - | 87-12-17 | |
Director/Board Member | - | - | |
Chairman | - | 10-12-31 | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 179,393,939 | 29,501,044 ( 16.44 %) | 1,713,200 ( 0.9550 %) | 16.44 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.17% | 358M | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- BLAU3 Stock
- Company Blau Farmacêutica S.A.